randomised/double blind/case-control/control without pelacebo Inclusion criteria:choronic obstructive pulmonary diseases patients with FEV1/FVC<0/7 and FEV1<50%;negative past medical history of vitamines D disorders exclusion criteria:positive past medical history of vitamine D disorders target sample size:88 patients in case group have intervated with oral agents vitamineD(in 6 months with doses100000internationalunits of vitamine D3 monthly within 6months)and routin drugthrapy for choronic obstructive pulmonary diseases .patients in control group have treatment wiyh routin drugs for choronic obstructive pulmonary diseases. duration of intervention:1390/12/15-1391/07/15
General information
Acronym
IRCT registration information
IRCT registration number:IRCT2012071810332N1
Registration date:2012-08-07, 1391/05/17
Registration timing:registered_while_recruiting
Last update:
Update count:0
Registration date
2012-08-07, 1391/05/17
Registrant information
Name
Elham Senisel bachari
Name of organization / entity
Khorramabadmedical university
Country
Iran (Islamic Republic of)
Phone
+98 916 333 3143
Email address
eli2shim@yahoo.com
Recruitment status
Recruitment complete
Funding source
Khorramabad University Of Medical Sciences
Expected recruitment start date
2012-03-05, 1390/12/15
Expected recruitment end date
2012-10-06, 1391/07/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of Effects Oral Supplements Vitamine D on COPD Exacerbation and FEV1 in Patients With Severe and Very Severe COPD
Public title
Effects Oral Agents Vitamine D On COPD
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusioncriteria:COPD patients with FEV1/FVC<0/7 and FEV1<50%;negative past medical history of vitamines D disorders
exclusion criteria:positive past medical history of vitamine D disorders
Added at 2012-08-07: chronic obstructive pulmonary diseases
ICD-10 code
Added at 2
ICD-10 code description
Added at 2012-08-07:
Primary outcomes
1
Description
FEV1
Timepoint
Before intervention and after intervention
Method of measurement
Spirometery(PFT)
Secondary outcomes
1
Description
COPD Exacerbation
Timepoint
Before and mean and afterof intervention
Method of measurement
Physical exam
Intervention groups
1
Description
patients in case group have intervened with oral agents vitamineD(in 6 months with doses100000internationalunits of vitamin D3 monthly within 6months)and routin drugthrapy for Chronic obstructive pulmonary diseases.patients
Category
Prevention
2
Description
in control group have treatment with routine drugs for Chronic obstructive pulmonary diseases